List View Detail View 301-325 of 408 items Sort by: Best Match Name Clone Applications Regulatory Status Previous 1 ... 12 13 14 ... 17 Next Product Clone Appl. Reg Cat# Size Price Quantity Brilliant Violet 421™ anti-human CD326 (EpCAM) Antibody CO17-1A FC RUO 369821 25 tests 182 CHF 369822 100 tests 402 CHF Alexa Fluor® 647 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC, ICC, IHC-F, 3D IHC, SB RUO 147307 25 µg 124 CHF 147308 100 µg 323 CHF APC anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC RUO 147311 25 µg 154 CHF 147312 100 µg 332 CHF APC/Fire™ 750 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC RUO 147313 25 µg 171 CHF 147314 100 µg 375 CHF Alexa Fluor® 594 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 ICC, IHC-P, IHC-F, 3D IHC RUO 147306 100 µg 206 CHF PE anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC RUO 147303 25 µg 153 CHF 147304 100 µg 335 CHF PE/Dazzle™ 594 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC RUO 147315 25 µg 171 CHF 147316 100 µg 375 CHF PE/Cyanine7 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC RUO 147309 25 µg 124 CHF 147310 100 µg 370 CHF PerCP/Cyanine5.5 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC RUO 147317 25 µg 176 CHF 147318 100 µg 382 CHF Purified anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC, ICC, IP, WB, FA RUO 147301 25 µg 124 CHF 147302 100 µg 247 CHF TotalSeq™-A1465 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 PG RUO 147321 10 µg 369 CHF TotalSeq™-B1465 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 PG RUO 147323 10 µg 369 CHF TotalSeq™-C1465 anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 PG RUO 147325 10 µg 369 CHF Brilliant Violet 421™ anti-mouse/human CD324 (E-Cadherin) Antibody DECMA-1 FC RUO 147319 50 µg 253 CHF Biotin anti-mouse CD326 (Ep-CAM) Antibody G8.8 FC RUO 118203 50 µg 89 CHF FITC anti-mouse CD326 (Ep-CAM) Antibody G8.8 FC RUO 118207 50 µg 101 CHF See more size options for this product on the next page. Results Per Page: 25 50 100 200 Previous 1 ... 12 13 14 ... 17 Next
Follow Us